Czech Republic – Heparinum natricum II.

By: Institute of Clinical and Experimental Medicine📍 Czech RepublicOpen

Key Information

ReferenceGB-786056-2026
DeadlineDec 16, 2026 12:00 AM
Estimated ValueCZK 41,786,000.00
CategoryAdvertising & Media
Competition TypeICB
Funding SourceSelf-Funded
CountryCzech Republic
AddressVídeňská 1958, Prague, 14000, Czech Republic
PublishedNov 11, 2026

Description

2. Procedure2.1.ProcedureTitle: Heparinum natricum II.Description: The subject of the public contract is the supply of medicinal products containing the active ingredient heparinum natricum (ATC B01AB...

Full details are available after unlocking this tender.

Generated from Tender Access Hub · Nov 12, 2026 11:26 PM